Your search results.

Pages

  1. BIVI FLEXcombo® swine vaccine now available in a 50-dose presentation

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 35.06 kB
    • Last Update: 22.04.2016
  2. Leading Animal Health Company, Boehringer Ingelheim Vetmedica, Inc., Announces Website Redesign

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 34.21 kB
    • Last Update: 22.04.2016
  3. Pyramid® 5 + Presponse® SQ Approved for Extended BVD 1b Protection

    Build immunity against the most common form of BVD in persistently infected calves

    • Size: 35.59 kB
    • Last Update: 25.04.2016
  4. Latest At The Meeting series focuses on applied PRRS research & ARC

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 35.79 kB
    • Last Update: 22.04.2016
  5. Boehringer Ingelheim launches SOURCE for PED management information

    About Boehringer Ingelheim Vetmedica, Inc.

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets.  BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH.  Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 35.31 kB
    • Last Update: 28.03.2016
  6. 2015 BIVI PRRS Research Awards Announced at AASV Conference

    About Boehringer Ingelheim Vetmedica, Inc.

    The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

    • Size: 39.08 kB
    • Last Update: 27.04.2016
  7. Boehringer Ingelheim Vetmedica Inc. Granted Conditional License for Equine Pigeon Fever Vaccine*

    About Boehringer Ingelheim

    Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

    • Size: 36.44 kB
    • Last Update: 22.04.2016
  8. New option for vaccinating against pneumonia caused by M. haemolytica

    Pyramid and Presponse are registered trademarks of Boehringer Ingelheim Vetmedica, Inc.

    • Size: 37.65 kB
    • Last Update: 25.04.2016
  9. BIVI Awards Second $50,000 in Grants for PED Data Sharing Programs

    UC Davis, Iowa State University and Univ. of Minnesota recipients of grant

    • Size: 35.03 kB
    • Last Update: 28.03.2016
  10. Nominations now accepted for new Champions of the Cause Award presented by Boehringer Ingelheim Vetmedica, Inc., and EquiManagement

    Nominations now accepted for new Champions of the Cause Award presented by Boehringer Ingelheim Vetmedica, Inc., and EquiManagement

    • Size: 34.08 kB
    • Last Update: 18.04.2016

Pages